Publikationen, an denen er mitarbeitet Marco Perez (2)

2016

  1. Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src [Oncotarget, 7, 22, (33111-33124) (2016)] DOI: 10.18632/oncotarget.8880

    Oncotarget

  2. Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

    Oncotarget, Vol. 7, Núm. 22, pp. 33111-33124